MedTrace Logo

Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation

NCT00965874 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2018-04-20

No results posted yet for this study

Summary

Objective:

To assess the efficacy and the safety of high (9g) and low dose (4.5g) of MgS in the immediate treatment of rapid AF.

Conditions

Interventions

DRUG

Magnesium Sulfate high dose

9 g infusion once during 30 minutes

DRUG

Magnesium Sulfate low dose

4.5 g magnesium sulfate infusion

DRUG

Placebos

serum salin

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • nouira semir, MD · University of Monastir

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2014-04-30
Completion
2014-08-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00965874 on ClinicalTrials.gov